Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Cancers
|
June 10, 2022
PSMA PET-CT Imaging Predicts Treatment Progression in Men with Biochemically Recurrent Prostate Cancer-A Prospective Study of Men with 3 Year Follow Up
Sean Ong, Claire Pascoe, Brian D Kelly, et al.
AIDS Education and Prevention : Official Publication of the International Society for AIDS Education
|
October 28, 2006
Using community-based participatory research to develop an intervention to reduce HIV and STD infections among Latino men
Scott D Rhodes, Kenneth C Hergenrather, Jaime Montaño, et al.
Radiation Oncology (London, England)
|
July 25, 2022
Dose-escalated radiotherapy to 82 Gy for prostate cancer following insertion of a peri-rectal hydrogel spacer: 3-year outcomes from a phase II trial
Andrew W See, Patrick Bowden, Geoffrey Wells, et al.
BJU International
|
May 16, 2023
Can <sup>68</sup> Ga-PSMA positron emission tomography and multiparametric MRI guide treatment for biochemical recurrence after radical prostatectomy?
Yash Khanna, Vidyasagar Chinni, Kavitha Gnanasambantham, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 12, 2011
Benchmarking dosimetric quality assessment of prostate intensity-modulated radiotherapy
Sashendra Senthi, Suki S Gill, Annette Haworth, et al.
Clinical and Translational Radiation Oncology
|
March 31, 2025
Stereotactic body radiotherapy for lung oligometastatic prostate cancer: An international retrospective multicenter study
Maximilien Rogé, Patrick Bowden, Paul Conway, et al.
BJU International
|
January 8, 2026
Does addition of multiparametric MRI to PSMA PET/CT improve diagnostic accuracy for biochemical recurrence after radical prostatectomy?
Yash Khanna, Vidyasagar Chinni, Kavitha Gnanasambantham, et al.
International Journal of Cancer
|
June 20, 2024
Five-year outcomes of fractionated stereotactic body radiotherapy for oligometastatic prostate cancer from the TRANSFORM phase II trial
Andrew W See, Paul Conway, Mark Frydenberg, et al.
BJU International
|
June 25, 2020
Use of prostate-specific membrane antigen positron-emission tomography/CT in response assessment following upfront chemohormonal therapy in metastatic prostate cancer
Angelyn Anton, Olfat Kamel Hasan, Zita Ballok, et al.
International Journal of Cancer
|
June 15, 2019
Fractionated stereotactic body radiotherapy for up to five prostate cancer oligometastases: Interim outcomes of a prospective clinical trial
Patrick Bowden, Andrew W See, Mark Frydenberg, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Cancers
|
June 10, 2022
PSMA PET-CT Imaging Predicts Treatment Progression in Men with Biochemically Recurrent Prostate Cancer-A Prospective Study of Men with 3 Year Follow Up
Sean Ong, Claire Pascoe, Brian D Kelly, et al.
AIDS Education and Prevention : Official Publication of the International Society for AIDS Education
|
October 28, 2006
Using community-based participatory research to develop an intervention to reduce HIV and STD infections among Latino men
Scott D Rhodes, Kenneth C Hergenrather, Jaime Montaño, et al.
Radiation Oncology (London, England)
|
July 25, 2022
Dose-escalated radiotherapy to 82 Gy for prostate cancer following insertion of a peri-rectal hydrogel spacer: 3-year outcomes from a phase II trial
Andrew W See, Patrick Bowden, Geoffrey Wells, et al.
BJU International
|
May 16, 2023
Can <sup>68</sup> Ga-PSMA positron emission tomography and multiparametric MRI guide treatment for biochemical recurrence after radical prostatectomy?
Yash Khanna, Vidyasagar Chinni, Kavitha Gnanasambantham, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 12, 2011
Benchmarking dosimetric quality assessment of prostate intensity-modulated radiotherapy
Sashendra Senthi, Suki S Gill, Annette Haworth, et al.
Clinical and Translational Radiation Oncology
|
March 31, 2025
Stereotactic body radiotherapy for lung oligometastatic prostate cancer: An international retrospective multicenter study
Maximilien Rogé, Patrick Bowden, Paul Conway, et al.
BJU International
|
January 8, 2026
Does addition of multiparametric MRI to PSMA PET/CT improve diagnostic accuracy for biochemical recurrence after radical prostatectomy?
Yash Khanna, Vidyasagar Chinni, Kavitha Gnanasambantham, et al.
International Journal of Cancer
|
June 20, 2024
Five-year outcomes of fractionated stereotactic body radiotherapy for oligometastatic prostate cancer from the TRANSFORM phase II trial
Andrew W See, Paul Conway, Mark Frydenberg, et al.
BJU International
|
June 25, 2020
Use of prostate-specific membrane antigen positron-emission tomography/CT in response assessment following upfront chemohormonal therapy in metastatic prostate cancer
Angelyn Anton, Olfat Kamel Hasan, Zita Ballok, et al.
International Journal of Cancer
|
June 15, 2019
Fractionated stereotactic body radiotherapy for up to five prostate cancer oligometastases: Interim outcomes of a prospective clinical trial
Patrick Bowden, Andrew W See, Mark Frydenberg, et al.
Page
of 3